Amkor (AMKR) Q1 2026 Earnings Call Transcript

Amkor delivered record Q1 revenue of $1.68 billion, up 27% year over year, with gross margin expanding to 14.2%, operating income up to $100 million, and EPS rising to $0.33. Management guided Q2 revenue to $1.75 billion-$1.85 billion and said AI/data-center packaging revenue remains on track to triple in 2026, while noting supply-chain delays and pricing pressure that could push out $50 million-$100 million of revenue per quarter. The company also reiterated $2.5 billion-$3.0 billion of 2026 capex for Arizona and advanced packaging expansion, implying continued growth but some margin dilution starting in 2027 from the Arizona buildout.

Analysis

The key signal is not just that utilization is recovering, but that the mix of demand is shifting toward the scarce, qualification-gated parts of the portfolio. That usually matters more than headline growth because it pushes the company into a regime where pricing power can lag unit growth by a quarter or two, then re-rate sharply once customers accept pass-throughs and package constraints become visible. In other words, near-term revenue appears less important than the fact that advanced packaging is now becoming the bottleneck and the bargaining lever.

The second-order winner is the company’s upstream ecosystem: substrate, advanced silicon, memory, and equipment vendors should see tighter order discipline and less pricing give-back if this ramp extends into the second half. The obvious losers are lower-value OSAT peers and mainstream test/assembly suppliers that cannot participate in the high-margin AI/heterogeneous integration mix; they risk being left with commodity loading while the premium work is concentrated in a few qualified nodes and geographies. The more interesting competitive implication is that customers are effectively funding capacity to de-risk their own roadmaps, which reduces the odds of a demand cliff but increases the probability of a multi-year capacity subscription model.

The market may be underestimating the timing asymmetry around Arizona: the stock can stay supported on 2026/2027 growth visibility, but the next leg of margin dilution is a 2027 story while the meaningful revenue scale is pushed toward 2028-2029. That creates a classic second-half-of-the-cycle setup where investors may overpay for the visible ramp and then get impatient during the construction/qualification overlap. The contrarian takeaway is that the current positivity is justified on execution, but the easy upgrade path may already be in the print; the real catalyst is the Investor Day, where management can either quantify a higher terminal margin rate or expose how much of the future is already committed by capex and customer support.

Key Decisions for Investors

• Go long AMKR on a 3-6 month horizon, but size as a catalyst trade into Investor Day (May 21): upside is best captured if management quantifies a steeper 2027-2029 margin ramp; risk is a ‘show-me’ response if guidance stays qualitative.
• Pair trade: long AMKR / short a lower-quality OSAT or mainstream packaging name with weaker AI exposure over the next 1-2 quarters; thesis is mix and pricing divergence as advanced packaging captures the scarce capacity premium.
• Buy AMKR call spreads expiring after Q3 earnings to express upside from the compute ramp without paying for full multiple expansion; best risk/reward if the HDFO contribution shows up earlier than consensus.
• Monitor TSM and INTC as indirect beneficiaries of advanced packaging capacity relief; if AMKR’s capacity additions de-risk their roadmaps, expect continued share of wallet migration toward validated partners.
• Avoid chasing the stock on a one-day post-earnings pop; the bigger entry point may come if the market fixates on 2027 Arizona dilution before the 2028-2029 earnings leverage becomes visible.